Elucidating the link between Chlamydia trachomatis and ectopic pregnancy

rollout of the NCSP was completed. This offers screening to anyone under the age of 25 years who is sexually active [101]. The NCSP cost an estimated GB£42 million in 2008–2009 and over GB£150 million has been spent since its launch [102]. In Scotland no such program has been introduced. The Scottish Intercollegiate Guidelines Network (SIGN) state that “in the absence of a complication rate of 10% or more in women with untreated chlamydial infection, there is no evidence that a screening program is cost effective with regard to reducing morbidity” [103]. Furthermore, the National Institute for Health and Clinical Excellence (NICE) have recently recommended that C. trachomatis screening should not be offered to pregnant women, based on the evidence supporting the NICE Routine Antenatal Care Guideline (March 2008) [104].